Medicine for treating phlegm clouding clear orifices obstructive emphysema and preparation method of medicine

Abstract

The invention discloses a medicine for treating phlegm clouding clear orifices obstructive emphysema, which comprises the following active ingredients: rhizoma phragmitis, rhizoma decumbentis, cordate houttuynia, Indian iphigenia bulb, folium sennae, aloe, lilac daphne flower bud, semen persicae, ganoderma lucidum, polygala tenuifolia, rhizoma acori graminei, tussilago, folium eriobotryae, semen lepidii, folium rhododendri daurici, momordica grosvenori, gleditsia sinensis, inula flower, concretio silicea bambusae, seaweed, fritillaria cirrhosa, snakegourd fruit, bamboo juice, sea clam shells, chlorite schist, platycodon grandiflorum, boat-fruited sterculia seeds, pummelo peel and semen pharbitidis. The medicine has an effect of removing phlegm to enlighten and mainly treats the phlegm clouding clear orifices obstructive emphysema. The medicine employs the traditional Chinese medicine theory, improves overall immunity of an organism and pathogenic evil resistance, reduces complications, increases a cure rate, reduces a recurrence rate, is wide in medicine resource, has smaller toxic and side effects and low possibility of medicine tolerance, is convenient to administer, is easily accepted by a patient, can alleviate mental stress of a patient obviously, improves life quality of the patient and can be used for clinical market popularization.

Description

technical field [0001] The invention relates to a medicine containing raw materials derived from plants, animals or minerals, in particular to a medicine for treating obstructive emphysema of phlegm-meng-shenqiao type and a preparation method thereof. Background technique [0002] Obstructive emphysema is chronic obstructive pulmonary emphysema, strictly speaking emphysema is not a disease in its own right but an anatomical / structural term that results from the development of chronic bronchitis or other chronic lung disease. Mainly the expansion and hyperinflation of the distal part of the terminal bronchi of lung tissue, including respiratory bronchioles, alveolar ducts, alveolar sacs, and alveoli, resulting in decreased elasticity and increased volume of lung tissue. Because of its slow onset and long course, it is called chronic obstructive emphysema. In my country, the incidence rate is about 0.6% to 4.3%. [0003] Etiology: 1. Smoking: Cigarettes contain a varie...

AI Technical Summary

Problems solved by technology

[0007] Western medicine treatment of chronic obstructive emphysema should use chemical synthetic drugs such as expectorants, antibacterial drugs, and bronchodilators as appropriate; the course of treatment is longer, drug resistance is prone to occur, and adverse reactions are more, protracted and difficult to heal, and the condition is repeated. Unsatisfactory, causing financial burden and mental pressure to patients and their families, and significantly reducing their quality of life, etc.

Images